Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NYSE:ENZ

Enzo Biochem (ENZ) Stock Price, News & Analysis

Enzo Biochem logo

About Enzo Biochem Stock (NYSE:ENZ)

Advanced Chart

Key Stats

Today's Range
$0.31
$0.40
50-Day Range
$0.33
$0.33
52-Week Range
$0.25
$1.19
Volume
4.12 million shs
Average Volume
173,401 shs
Market Capitalization
$17.03 million
P/E Ratio
N/A
Dividend Yield
123.08%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive ENZ Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Enzo Biochem and its competitors with MarketBeat's FREE daily newsletter.

ENZ Stock News Headlines

ENZB - Enzo Biochem Inc Dividends - Morningstar
Microsoft's Next Big Bet?
Microsoft just broke ground on a revolutionary power system that could deliver virtually limitless, carbon-free energy. Bill Gates calls it “abundant” and is backing four separate startups in the space. While most of these plays are off-limits to everyday investors, a little-known backdoor could give you access to one tiny company leading the charge—and it’s publicly traded.
Enzo Biochem: Fiscal Q3 Earnings Snapshot
See More Headlines

ENZ Stock Analysis - Frequently Asked Questions

Enzo Biochem, Inc. (NYSE:ENZ) issued its earnings results on Monday, March, 17th. The medical research company reported ($0.02) earnings per share (EPS) for the quarter. The medical research company had revenue of $7.33 million for the quarter. Enzo Biochem had a negative trailing twelve-month return on equity of 7.96% and a negative net margin of 75.34%.

Based on aggregate information from My MarketBeat watchlists, some other companies that Enzo Biochem investors own include Zomedica (ZOM), Jumia Technologies (JMIA), Nano Dimension (NNDM), NIO (NIO), AST SpaceMobile (ASTS), Virgin Galactic (SPCE) and OneLife Technologies (OLMM).

Company Calendar

Last Earnings
3/17/2025
Today
8/02/2025
Fiscal Year End
7/31/2026

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
Medical laboratories
Sub-Industry
Healthcare
Current Symbol
NYSE:ENZ
CIK
316253
Employees
520
Year Founded
1976

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$26.08 million
Net Margins
-75.34%
Pretax Margin
-23.79%
Return on Equity
-7.96%
Return on Assets
-5.49%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
2.55
Quick Ratio
2.28

Sales & Book Value

Annual Sales
$29.09 million
Price / Sales
0.59
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$1.09 per share
Price / Book
0.30

Miscellaneous

Outstanding Shares
52,403,000
Free Float
46,288,000
Market Cap
$17.03 million
Optionable
Optionable
Beta
1.19

Social Links

Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report

This page (NYSE:ENZ) was last updated on 8/2/2025 by MarketBeat.com Staff
From Our Partners